BiotechTube
Home/Okogen/Bradford A. Conlan
BA

Bradford A. Conlan

Executive Chairman

Okogen

Therapeutic Areas

OphthalmologyInfectious Disease

Okogen Pipeline

DrugIndicationPhase
OKG-0303Acute Infectious Conjunctivitis (Bacterial and Viral)Phase 2b

Leadership Team at Okogen

JH
Joshua H. Moriarty
Chief Executive Officer & Director
DA
David A. Hollander, MD, MBA
Chief Medical Officer
BM
Brian M Strem, PhD
Non-Executive Director, Co-founder
View full Okogen profile